Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia

about

Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia

Item

http://www.wikidata.org/entity/Q55540751

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Comparative Cost-Effectiveness ...... lomavirus Vaccines in Malaysia

@en

Comparative Cost-Effectiveness ...... lomavirus Vaccines in Malaysia

@nl

type

Item

label

Comparative Cost-Effectiveness ...... lomavirus Vaccines in Malaysia

@en

Comparative Cost-Effectiveness ...... lomavirus Vaccines in Malaysia

@nl

prefLabel

Comparative Cost-Effectiveness ...... lomavirus Vaccines in Malaysia

@en

Comparative Cost-Effectiveness ...... lomavirus Vaccines in Malaysia

@nl

P1476

Comparative Cost-Effectiveness ...... lomavirus Vaccines in Malaysia

@en

P2093

Chee-Meng Yong

http://www.w3.org/2001/XMLSchema#string

Georges Van Kriekinge

http://www.w3.org/2001/XMLSchema#string

I-Heng Lee

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Ruey Soon

http://www.w3.org/2001/XMLSchema#string

Syed Mohamed Aljunid

http://www.w3.org/2001/XMLSchema#string

Woo-Yun Sohn

http://www.w3.org/2001/XMLSchema#string

P2860

Role of human papillomaviruses in carcinogenesis

Long-term efficacy and safety of human papillomavirus vaccination

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

Human papillomavirus vaccines: WHO position paper, October 2014

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities.

Cost-effectiveness of different human papillomavirus vaccines in Singapore

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

P304

933-940

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22034/APJCP.2018.19.4.933

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29693347

http://www.w3.org/2001/XMLSchema#string

P921

An Mhalaeisia

P932

6031794

http://www.w3.org/2001/XMLSchema#string